AVEO Annual Cash & Cash Equivalents
$70.54 M
+$8.78 M+14.22%
31 December 2021
Summary:
As of January 19, 2025, AVEO annual cash & cash equivalents is $70.54 million, with the most recent change of +$8.78 million (+14.22%) on December 31, 2021. During the last 3 years, it has risen by +$46.12 million (+188.79%).AVEO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVEO Quarterly Cash And Cash Equivalents
$77.40 M
+$7.23 M+10.30%
30 September 2022
Summary:
As of January 19, 2025, AVEO quarterly cash and cash equivalents is $77.40 million, with the most recent change of +$7.23 million (+10.30%) on September 30, 2022. Over the past year, it has increased by +$8.56 million (+12.43%).AVEO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVEO Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.2% | +12.4% |
| 3 y3 years | +188.8% | +34.3% |
| 5 y5 years | +371.9% | +373.3% |
AVEO Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -7.3% | -36.3% |
AVEO Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $77.40 M(+10.3%) |
| June 2022 | - | $70.17 M(-5.0%) |
| Mar 2022 | - | $73.85 M(+4.7%) |
| Dec 2021 | $70.54 M(+14.2%) | $70.54 M(+2.5%) |
| Sept 2021 | - | $68.84 M(-7.9%) |
| June 2021 | - | $74.73 M(-38.4%) |
| Mar 2021 | - | $121.41 M(+96.6%) |
| Dec 2020 | $61.76 M(+107.4%) | $61.76 M(+55.0%) |
| Sept 2020 | - | $39.85 M(-12.7%) |
| June 2020 | - | $45.67 M(+94.7%) |
| Mar 2020 | - | $23.46 M(-21.2%) |
| Dec 2019 | $29.79 M(+21.9%) | $29.79 M(-48.3%) |
| Sept 2019 | - | $57.65 M(+43.3%) |
| June 2019 | - | $40.23 M(+71.3%) |
| Mar 2019 | - | $23.48 M(-3.9%) |
| Dec 2018 | $24.43 M(+63.4%) | $24.43 M(+19.7%) |
| Sept 2018 | - | $20.41 M(+12.8%) |
| June 2018 | - | $18.09 M(+11.9%) |
| Mar 2018 | - | $16.16 M(+8.1%) |
| Dec 2017 | $14.95 M(-1.0%) | $14.95 M(-8.6%) |
| Sept 2017 | - | $16.35 M(-47.0%) |
| June 2017 | - | $30.86 M(-7.6%) |
| Mar 2017 | - | $33.41 M(+121.3%) |
| Dec 2016 | $15.10 M(-43.3%) | $15.10 M(+22.0%) |
| Sept 2016 | - | $12.37 M(-51.2%) |
| June 2016 | - | $25.33 M(+40.3%) |
| Mar 2016 | - | $18.06 M(-32.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $26.63 M(-49.1%) | $26.63 M(-23.3%) |
| Sept 2015 | - | $34.74 M(+29.8%) |
| June 2015 | - | $26.77 M(-22.5%) |
| Mar 2015 | - | $34.53 M(-34.0%) |
| Dec 2014 | $52.31 M(+2.9%) | $52.31 M(-12.8%) |
| Sept 2014 | - | $59.98 M(+38.3%) |
| June 2014 | - | $43.36 M(-6.4%) |
| Mar 2014 | - | $46.34 M(-8.8%) |
| Dec 2013 | $50.83 M(-33.2%) | $50.83 M(+0.8%) |
| Sept 2013 | - | $50.42 M(+49.1%) |
| June 2013 | - | $33.82 M(-60.6%) |
| Mar 2013 | - | $85.90 M(+12.8%) |
| Dec 2012 | $76.13 M(+75.0%) | $76.13 M(-33.3%) |
| Sept 2012 | - | $114.10 M(+33.0%) |
| June 2012 | - | $85.79 M(+17.4%) |
| Mar 2012 | - | $73.06 M(+67.9%) |
| Dec 2011 | $43.51 M(-5.0%) | $43.51 M(-5.2%) |
| Sept 2011 | - | $45.91 M(-43.3%) |
| June 2011 | - | $81.01 M(-19.8%) |
| Mar 2011 | - | $101.08 M(+120.7%) |
| Dec 2010 | $45.79 M(+1.1%) | $45.79 M(+14.3%) |
| Sept 2010 | - | $40.05 M(+33.4%) |
| June 2010 | - | $30.02 M(-58.1%) |
| Mar 2010 | - | $71.65 M(+58.2%) |
| Dec 2009 | $45.29 M(+117.6%) | $45.29 M(+12.7%) |
| Sept 2009 | - | $40.18 M(+93.1%) |
| Dec 2008 | $20.81 M(-1.3%) | $20.81 M |
| Dec 2007 | $21.08 M | - |
FAQ
- What is AVEO Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AVEO Pharmaceuticals?
- What is AVEO Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is AVEO Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for AVEO Pharmaceuticals?
- What is AVEO Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is AVEO Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of AVEO is $70.54 M
What is the all time high annual cash & cash equivalents for AVEO Pharmaceuticals?
AVEO Pharmaceuticals all-time high annual cash & cash equivalents is $76.13 M
What is AVEO Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, AVEO annual cash & cash equivalents has changed by +$8.78 M (+14.22%)
What is AVEO Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AVEO is $77.40 M
What is the all time high quarterly cash and cash equivalents for AVEO Pharmaceuticals?
AVEO Pharmaceuticals all-time high quarterly cash and cash equivalents is $121.41 M
What is AVEO Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, AVEO quarterly cash and cash equivalents has changed by +$8.56 M (+12.43%)